Please login to the form below

Not currently logged in
Email:
Password:

Germany

This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

Currently, Abivax has received approval for studies in France and Germany, as well as in the UK, Italy and Brazil.

Latest news

More from news
Approximately 45 fully matching, plus 853 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 9 fully matching, plus 127 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 75 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 74 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics